CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong

Cancer Research and Treatment. 2018;50(3):646-657. Published online 2017 July 17 DOI: https://doi.org/10.4143/crt.2016.550

Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma

Eun-Jung Lee, Seung-Hyun Yang, Kyoung-Jin Kim, Hyejung Cha, Seo Jin Lee, Ji-Hye Kim, Junkyu Song, Kyung-Hee Chun, Jinsil Seong

Cancer Research and Treatment. 2018;50(3):646-657

Link1

Link2 Link3

P556 INTER-ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4 AS DIAGNOSTIC AND PROGNOSTIC INDICATOR IN PATIENTS WITH HEPATITIS B VIRUS ASSOCIATED HEPATOCELLULAR CARCINOMA

S.S. Kim, C.K. Noh, H.J. Cho, S.J. Ahn, S.W. Cho, J.Y. Cheong

Journal of Hepatology. 2014;60(1):S254

Link1 Link2

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

M. Gilabert, JL. Raoul

Journal of Hepatocellular Carcinoma. 2018;Volume 5:91-98

Link1 Link2

Predicting Outcomes of Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Daniel J. Firl, Kazunari Sasaki, Federico N. Aucejo

Gastroenterology. 2018;154(6):1856-1857

Link1 Link2

Inter-alpha inhibitor proteins—biomarker for NEC?

Alan H. Jobe

The Journal of Pediatrics. 2010;157(5):A2

Link1 Link2

Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib

H.J. Cho, S.S. Kim, S.W. Cho, J.Y. Cheong

Journal of Hepatology. 2017;66(1):S467-S468

Link1 Link2

Predicting the posttransplant prognosis of patients with hepatocellular carcinoma: What lies beneath alpha-fetoprotein?

Edoardo G. Giannini, Vincenzo Savarino

Liver Transplantation. 2013;19(10):1166-1167

Link1 Link2 Link3

Noninvasive Biomarker for Predicting Treatment Response to Concurrent Chemoradiotherapy in Patients with Hepatocellular Carcinoma

Yong Eun Chung, Jun Yong Park, Jin-Young Choi, Myeong-Jin Kim, Mi-suk Park, Jinsil Seong

Investigative Magnetic Resonance Imaging. 2019;23(4):351

Link1 Link2 Link3

Serum lnc34a is a Potential Prediction Biomarker for Bone Metastasis in Hepatocellular Carcinoma Patients

Li Zhang, Hao Niu, Ping Yang, Jie Ma, Bao-Ying Yuan, Zhao-Chong Zeng, Zuo-Lin Xiang

. 2020;

Link1 Link2

Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma

Tudor Mocan, Maria Ilies, Iuliana Nenu, Rares Craciun, Adelina Horhat, Ruxandra Susa, Iulia Minciuna, Ioana Rusu, Lavinia-Patricia Mocan, Andrada Seicean, Cristina Adela Iuga, Nadim Al Hajjar, Mihaela Sparchez, Daniel-Corneliu Leucuta, Zeno Sparchez

International Immunopharmacology. 2021;94:107467

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.